Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
l-epigallocatechin (1 trial)
nintedanib (ofev) (1 trial)
temozolomide (temodar) (1 trial)
Amyloidosis (Phase 2)
Glioblastoma (Phase 2)
Trials (3 total)
Trial APIs (3 total)